A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

Published:2019-03-29 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Caussy Cyrielle,Tripathi Anupriya,Humphrey Greg,Bassirian Shirin,Singh Seema,Faulkner Claire,Bettencourt Ricki,Rizo Emily,Richards Lisa,Xu Zhenjiang Z.,Downes Michael R.,Evans Ronald M.,Brenner David A.,Sirlin Claude B.,Knight Rob^ORCID,Loomba Rohit

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09455-9.pdf

Reference64 articles.

1. Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123–133 (2018).

2. Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686–690 (2013).

3. Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11–20 (2018).

4. Dulai, P. S. et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology 65, 1557–1565 (2017).

5. Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908–922 (2018).

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Multifaceted Role of CIDEB: From Apoptosis to Lipid Metabolism and Liver Health;Livers;2024-08-27

2. Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism;Genes & Nutrition;2024-08-24

3. Prediction of symptomatic and asymptomatic bacteriuria in spinal cord injury patients using machine learning;2024-08-10

4. Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis of randomized controlled trials;Clinics and Research in Hepatology and Gastroenterology;2024-08

5. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD;Seminars in Liver Disease;2024-07-11